CamKIIa can directly or indirectly increase tau ser262 phosphorylation [53] and tau-dependent neurodegeneration which was reported to occur with axonal mitochondrial insufficiency [54], a feature at the intersection of tauopathy and post-TBI metabolic deficits. Here, MAPT is linked to tauopathy.